Matthew Lee

Clinical Lecturer

University of Glasgow

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (8)

Tor Biering-Sørensen

Professor

University of Copenhagen

DENMARK

View details

Naveed Sattar

Professor of Metabolic Medicine

University of Glasgow

UNITED KINGDOM

View details

Pardeep Jhund

University of Glasgow

UNITED KINGDOM

View details

Neil Mehta

Professor and Assoc Dean (Curricular Affairs)

Cleveland Clinic

UNITED STATES

View details

Mark Petrie

University of Glasgow

UNITED KINGDOM

View details

Ross T Campbell

University of Glasgow

UNITED KINGDOM

View details

Kieran Docherty

University of Glasgow

UNITED KINGDOM

View details

Caroline Coats

University of Glasgow

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Matthew Lee

Research Interests

Explore related searches

Contact this professor

Articles (20)

Aficamten and Cardiopulmonary Exercise Test Performance

Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial

Effect of Aficamten on Cardiac Structure and Function in Obstructive Hypertrophic Cardiomyopathy

Reverse cardiac remodelling: VICTORIA for inflammation and cardiac metabolism

Administration of ferric derisomaltose for iron deficiency and heart failure during hospital admission or at the clinic – insights from the IRONMAN trial

Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA‐HCM

Predictors of heart failure readmission and all-cause mortality in patients with acute heart failure

What the SELECT trial of semaglutide means for clinicians

What's new in heart failure? June–July 2024

What's new in heart failure? May–June 2024

A review of current key guidelines for managing high‐risk patients with diabetes and heart failure and future prospects

Influenza vaccination: Simple, safe, and effective for patients with ischaemic heart disease and heart failure

Dapagliflozin versus metolazone in heart failure resistant to loop diuretics

Lack of Benefit of Renin-Angiotensin System Inhibitors in COVID-19

Renin–angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysis

Efficacy of implantable haemodynamic monitoring in heart failure across ranges of ejection fraction: a systematic review and meta-analysis

Health‐related quality of life in acute heart failure: association between patient‐reported symptoms and markers of congestion

Effect of Empagliflozin on Kidney Biochemical and Imaging Outcomes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF)

Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A meta-analysis with the FREEDOM cardiovascular outcomes trial

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

Collaborators (8)

Tor Biering-Sørensen

Naveed Sattar

Pardeep Jhund

Neil Mehta

Mark Petrie

Ross T Campbell

Kieran Docherty

Caroline Coats

Make your next move.